Dividend-adjusted total return · S&P 500 uses VOO · Aug 5, 2026 – Nov 3, 2026HELXS&P 500 · VOO
Franklin Genomic Advancements ETFHELX
$44.45
+2.0% last session
+22.4% YTD
Data as of 11/3/20264:00 PM ET · End-of-day
| Returns | 1D | 1M | 3M | YTD | 1Y | 3Y | 5Y | MAX |
|---|---|---|---|---|---|---|---|---|
| Total return | +2.0% | −1.7% | +11.1% | +22.4% | +26.6% | +75.1% | −15.3% | +86.9% |
| Peer average | +0.6% | +4.0% | +6.1% | +21.0% | +29.0% | +81.2% | +28.9% | — |
| S&P 500 · VOO | +0.3% | −2.6% | −1.7% | +11.5% | +11.9% | +90.9% | +77.5% | — |
Key Statistics
Open all fund facts →- AUM
- $36M
- Expense ratio
- 0.50%
- Distribution yield
- 0.3%
- NAV
- $44.45
- Volume
- 5K
- Avg. volume 30D
- 11K
- High today
- $44.65
- Low today
- $44.20
- Previous close
- $43.58
- 52-week high
- $46.22
- 52-week low
- $31.24
- Our risk indicator
- 4/5
HELX in One Breath
HELX Among Health Care ETFs
YTDEnd-of-day Nov 4, 2026 · 33 Health care ETFs by YTD
$10,000 in HELX
5Y$10,000 in HELX became
$8,473
In the S&P 500 (VOO)
$17,749
Total return, dividends in · Oct 26, 2021 – Nov 3, 2026 · S&P 500 uses VOO
HELX’s Top Holdings
TodayNTRANatera9.5%GH9.5%KRYS4.6%LGND4.5%ADPT4.3%TWST3.6%BBIO3.2%MEDP2.8%VRTX2.8%UTHR2.8%LLY2.8%REGN2.5%TVTX2.3%CDNA2.3%VYLR2.2%TEM2.1%GRAL2.0%RGEN1.9%CRL1.7%NBIXARGX.JAZZ41 more
BiotechnologyMedical - DiagnosticsDrug Manufacturers - GeneralMedical - Healthcare Information ServicesMedical - InstrumentsAgricultural Inputs
Franklin Templeton HELX · 63 holdings · tile size = share of the fund · as of Nov 3, 2026
What HELX Holds
TodayBiotechnology51.1%
KRYS 4.6 · LGND 4.5 · ADPT 4.3 · TWST 3.6 · BBIO 3.2 · VRTX 2.8 · UTHR 2.8
Medical - Diagnostics & Research32.2%
NTRA 9.5 · GH 9.5 · MEDP 2.8 · CDNA 2.3 · GRAL 2.0 · CRL 1.7 · VCYT 1.1
Drug Manufacturers - General3.3%
LLY 2.8 · AZN.L
Medical - Healthcare Information Services3.2%
TEM 2.1 · HNGE 1.1
Medical - Instruments & Supplies2.9%
RGEN 1.9 · SRT3.DE
Agricultural Inputs2.6%
VYLR 2.2 · CTVA
Medical - Pharmaceuticals2.3%
KNSA 1.1 · RPRX 1.1 · LQDA
Franklin Templeton HELX · share of the fund by industry · as of Nov 3, 2026
Natera’s Share of HELX
Today9.5%
$95 of every $1,000 in HELX is Natera
Natera held by HELX
$3.4M
Franklin Templeton HELX · each square = $10 of $1,000 · as of Nov 3, 2026
HELX’s Share of Health Care ETFs
Today0.0%
of the $109B in 39 Health care ETFs
$35.6M0.0%
$49.1B45.0%
$19.1B17.5%
$40.8B37.4%
Health care ETF AUM · Nov 4, 2026
HELX Fee per $100 vs Peers
TodayExpense ratio · Health care peers · Nov 4, 2026
Inside HELX
63 holdings · as of Nov 3, 2026HELX
Franklin Genomic Advancements ETF
TodayBiotechnology51.1%KRYS4.6%LGND4.5%ADPT4.3%TWST3.6%BBIO3.2%VRTX2.8%UTHR2.8%REGN2.5%TVTX2.3%NBIXARGX.BJAZZBNTX24 more holdings14.3% of the fundMedical - Diagnostics32.2%NTRA9.5%GH9.5%MEDP2.8%CDNA2.3%GRAL2.0%CRL1.7%VCYTIQVTMOAQIA.DDrug Manufacturers - General3.3%LLYMedical - Healthcare Information Services3.2%TEMHNGEMedical - Instruments2.9%RGEN1.9%SRT3.Agricultural Inputs2.6%VYLRMedical - Pharmaceuticals2.3%KNSARPRXGKOSCDNSETON
Biotechnology51.1%KRYS4.6%LGND4.5%ADPT4.3%TWST3.6%BBIO3.2%32 more holdings28.1% of the fundMedical - Diagnostics32.2%NTRA9.5%GH9.5%MEDPCDNAGRALCRL6 moreDrug Manufacturers - General3.3%LLYMedical - Healthcare Information Services3.2%TEMMedical - Instruments2.9%RGENAgricultural Inputs2.6%VYLRMedical - Pharmaceuticals2.3%KNSARPRXGKOSCDNS
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | NTRA | Natera | 9.54% |
| 2 | GH | Guardant Health | 9.48% |
| 3 | KRYS | Krystal Biotech | 4.62% |
| 4 | LGND | Ligand Pharmaceuticals | 4.48% |
| 5 | ADPT | Adaptive Biotechnologies | 4.27% |
| 6 | TWST | Twist Bioscience | 3.58% |
| 7 | BBIO | Bridgebio Pharma | 3.23% |
| 8 | MEDP | Medpace | 2.81% |
| 9 | VRTX | Vertex Pharmaceuticals IN | 2.80% |
| 10 | UTHR | United Therapeutics | 2.80% |
BiotechnologyMedical - DiagnosticsDrug Manufacturers - GeneralMedical - Healthcare Information ServicesMedical - InstrumentsAgricultural InputsMedical - PharmaceuticalsMedical - DevicesSoftware - ApplicationDrug Manufacturers - SpecialtyOther
Franklin Templeton HELX · current holdings by weight · as of Nov 3, 2026 · each tile is one holding · top 20 = 68.8%
How It Compares
HELX
Franklin Genomic Advancements ETF’s Peers
YTDHealth care peers · YTD and past-year returns · as of Nov 4, 2026 · sorted by AUM
Head to Head
Put HELX head to head with XLV →XLV vs HELX
YTDYear to date
HELX wins+2.1 pts
Past year
XLV wins+3.1 pts
Fee
XLV winslower fee
Yield
XLV wins+1.1 pts
AUM
XLV1381.0× more
3–1XLV wins
SPDR XLV and Franklin Templeton HELX · year-to-date · as of Nov 4, 2026 · AUM not scored
HELX vs VOO
YTDHELX · Franklin Genomic Advancements
+22.4%
VOO · S&P 500
+11.5%
Gap
10.9 pts
Franklin Templeton HELX and Vanguard VOO · YTD total return · as of Nov 4, 2026
HELX vs Its Peer Average
YTDHELXAvsBPeer average
1D+2.0%+0.6%
1M−1.7%+4.0%
3M+11.1%+6.1%
YTD+22.4%+21.0%
1Y+26.6%+29.0%
3Y+75.1%+81.2%
5Y−15.3%+28.9%
3–4Peer average wins
38 Health care peers · each row scaled to its leader
The Details
HELX
Risk
1Y4/5our risk indicator
CalmerBumpier
Volatility · 1Y24.62%
Deepest drop · 1Y−18.0%
Lowest point · 5Y−51.6%
52-week range
$44.45
$31.24−3.8% from the high$46.22
Franklin Templeton HELX · past-year price moves · as of Nov 4, 2026
HELX
Fund Facts
Today2020launched Feb 25
Tracks[…]
Exchange · CUSIPCBOE · 35473P520
StructureETF
Leverage1x
Cost on $10,000$50 a year
Go deeper
Franklin Templeton HELX · fund facts · as of Nov 4, 2026
HELX
Payouts by Year
3Y$0.14per share, Dec 2025
Distribution yield0.3%
PaidOnce a year, in December
Latest ex-date · paidDec 30 · Jan 8, 2026
4 payouts added up$0.31 a share
Franklin Templeton HELX · distributions by ex-date · 2020–2025
All Fund FactsDocuments · trading · fees · every payout
Prospectus & Documents
SEC reported portfolio · 2026-06-30 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2026-03-31 ↗SEC reported portfolio · 2025-12-31 ↗SEC reported portfolio · 2025-09-30 ↗SEC reported portfolio · 2025-06-30 ↗summary prospectus · SEC 497K ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2025-03-31 ↗SEC reported portfolio · 2024-12-31 ↗SEC reported portfolio · 2024-09-30 ↗SEC reported portfolio · 2024-06-30 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2024-03-31 ↗
Trading & Liquidity
Net asset value$44.45
Premium / discount[…]
Median spread · 30D[…]
Volume today5K
Average volume · 30D11K
Shares outstanding[…]
Options[…]
Fees & Costs
Net expense ratio0.50%
Gross expense ratio[…]
Management fee[…]
Cost on $10,000 a year$50.00
Our risk indicator4/5
Estimated yearly cost excludes trading costs and assumes constant assets.
Distributions
| Ex-date | Paid | Per share |
|---|---|---|
| Dec 30, 2025 | Jan 8, 2026 | $0.14 |
| Dec 30, 2021 | Jan 7, 2022 | $0.0039 |
| Dec 13, 2021 | Dec 21, 2021 | $0.11 |
| Dec 14, 2020 | Dec 23, 2020 | $0.0518 |
Issuer contentFrom Franklin TempletonHear the strategy from the people behind HELX.No issuer videos have been published for this fund.Are you the issuer? Claim this fund →